Peptidomimetic Growth Hormone Secretagogues. Design Considerations and Therapeutic Potential

ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTPeptidomimetic Growth Hormone Secretagogues. Design Considerations and Therapeutic PotentialRavi P. Nargund, Arthur A. Patchett, Mark A. Bach, M. Gail Murphy, and Roy G. SmithView Author Information Departments of Medicinal Chemistry, Clinical Pharmacology, Clinical Sciences, and Biochemistry and Physiology, Merck Research Laboratories, P.O. Box 2000, Rahway, New Jersey 07065 Cite this: J. Med. Chem. 1998, 41, 17, 3103–3127Publication Date (Web):July 17, 1998Publication History Received23 May 1997Published online17 July 1998Published inissue 1 August 1998https://pubs.acs.org/doi/10.1021/jm970342ohttps://doi.org/10.1021/jm970342oreview-articleACS PublicationsCopyright © 1998 American Chemical SocietyRequest reuse permissionsArticle Views680Altmetric-Citations61LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Agonists,Peptides and proteins,Peptidomimetics,Receptors,Rodent models Get e-Alerts